Early Experience with the New XEN63 Implant in Primary Open-Angle Glaucoma Patients: Clinical Outcomes.
XEN
glaucoma
glaucoma surgery
intraocular pressure
minimally invasive glaucoma surgery
open-angle glaucoma
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Apr 2021
12 Apr 2021
Historique:
received:
18
03
2021
revised:
05
04
2021
accepted:
08
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The new XEN63 implant is a minimally invasive glaucoma surgery device with limited experience in real life. This retrospective study included open-angle glaucoma patients who underwent XEN63 implant, either alone or in combination with cataract surgery. Primary endpoints were the intraocular pressure (IOP) at month 3 and the incidence of serious adverse events. Twenty-three eyes of 23 patients were included. Mean age was 67.8 ± 15.3 years and 15 (65.2%) were women. Mean IOP was significantly lowered from 27.0 ± 7.8 mmHg at baseline to 12.2 ± 3.4 mmHg at month 3 (
Identifiants
pubmed: 33921311
pii: jcm10081628
doi: 10.3390/jcm10081628
pmc: PMC8069200
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Allergan
ID : N.A.
Références
J Ophthalmol. 2020 Mar 23;2020:4796548
pubmed: 32280523
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):983-996
pubmed: 30758653
Int J Ophthalmol. 2020 Aug 18;13(8):1250-1256
pubmed: 32821679
Ophthalmology. 2001 Nov;108(11):1943-53
pubmed: 11713061
J Cataract Refract Surg. 2015 Sep;41(9):1905-9
pubmed: 26482822
Eur J Ophthalmol. 2019 May;29(3):309-314
pubmed: 30145910
Eur J Ophthalmol. 2020 Aug 18;:1120672120952033
pubmed: 32811168
Ophthalmology. 2015 Jul;122(7):1308-16
pubmed: 25912144
Clin Exp Ophthalmol. 2019 Jul;47(5):581-587
pubmed: 30578661
Clin Ophthalmol. 2017 Aug 29;11:1583-1600
pubmed: 28919702
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004399
pubmed: 22972069
J Glaucoma. 2017 Dec;26(12):1130-1136
pubmed: 29035911
Clin Ophthalmol. 2020 Jun 30;14:1805-1832
pubmed: 32636610
Int Ophthalmol. 2018 Jun;38(3):1129-1134
pubmed: 28555256
Acta Ophthalmol Scand. 1995 Jun;73(3):255-60
pubmed: 7493240
F1000Res. 2017 Oct 27;6:1898
pubmed: 29333242
Ophthalmol Ther. 2017 Dec;6(2):233-241
pubmed: 28730285
Ophthalmology. 2012 Apr;119(4):694-702
pubmed: 22196977
Br J Ophthalmol. 2006 Jan;90(1):4-5
pubmed: 16361654
J Glaucoma. 2014 Jan;23(1):e60-8
pubmed: 24145291
Am J Ophthalmol. 2012 May;153(5):804-814.e1
pubmed: 22244522
Expert Rev Med Devices. 2018 Jan;15(1):47-59
pubmed: 29258404
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
J Cataract Refract Surg. 2020 Mar;46(3):441-450
pubmed: 32142041
Am J Ophthalmol. 2005 Jul;140(1):16-22
pubmed: 15939389
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1741-1750
pubmed: 31093766
PLoS One. 2017 Aug 29;12(8):e0183142
pubmed: 28850575
Lancet. 2004 May 22;363(9422):1711-20
pubmed: 15158634
Sci Rep. 2020 Nov 9;10(1):19337
pubmed: 33168873
Clin Ophthalmol. 2018 Nov 15;12:2331-2335
pubmed: 30532518
J Glaucoma. 2014 Aug;23(6):410-4
pubmed: 23459200
Ann Intern Med. 2013 Feb 19;158(4):271-9
pubmed: 23420235
Am J Ophthalmol. 2017 Nov;183:25-36
pubmed: 28784554
Semin Ophthalmol. 2019;34(2):93-97
pubmed: 30789072